BPMC

101.83

2.68% -2.805

시간 외 거래: 103.01 1.175 +1.15%

Blueprint Medicines Corp (BPMC)

개요 뉴스 가격 이력 옵션 체인 Financials BPMC 왜 하락? 토론 예측

전일 마감가:

$104.64

열려 있는:

$104.53

하루 거래량:

1.09M

Relative Volume:

1.04

시가총액:

$6.38B

수익:

$434.41M

순이익/손실:

$-128.05M

주가수익비율:

-48.26

EPS:

-2.11

순현금흐름:

$-250.52M

1주 성능:

+15.05%

1개월 성능:

+24.68%

6개월 성능:

+4.39%

1년 성능:

-5.00%

1일 변동 폭

$100.31

$104.78

1주일 범위

$87.03

$104.86

52주 변동 폭

$73.04

$121.90

Blueprint Medicines Corp Stock (BPMC) Company Profile

명칭

Blueprint Medicines Corp

부문

Healthcare (1176)

산업

Biotechnology (676)

전화

617-374-7580

주소

45 SIDNEY STREET, CAMBRIDGE, MA

직원

655

트위터

@BlueprintMeds

다음 수익 날짜

2024-10-30

최신 SEC 제출 서류

BPMC's Discussions on Twitter

BPMC을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
BPMC Blueprint Medicines Corp	101.83	6.38B	434.41M	-128.05M	-250.52M	-2.11
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.58	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.16	26.92B	3.81B	-644.79M	-669.77M	-6.24

Blueprint Medicines Corp Stock (BPMC) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-03-20	재개	Morgan Stanley	Equal-Weight
2025-03-18	개시	Wolfe Research	Outperform
2025-03-17	개시	Jefferies	Buy
2025-03-07	개시	Scotiabank	Sector Outperform
2024-11-14	개시	JP Morgan	Overweight
2024-10-24	개시	UBS	Neutral
2024-05-14	개시	Stephens	Overweight
2024-05-06	업그레이드	Leerink Partners	Underperform → Market Perform
2023-10-27	업그레이드	Oppenheimer	Perform → Outperform
2023-08-21	재확인	Needham	Buy
2023-07-31	업그레이드	Wells Fargo	Equal Weight → Overweight
2023-06-05	다운그레이드	SVB Securities	Market Perform → Underperform
2023-01-03	업그레이드	Wells Fargo	Underweight → Equal Weight
2022-12-14	개시	Needham	Buy
2022-11-02	다운그레이드	Oppenheimer	Outperform → Perform
2022-09-14	개시	Berenberg	Buy
2022-07-08	개시	Oppenheimer	Outperform
2022-06-27	개시	Wells Fargo	Underweight
2022-06-10	다운그레이드	Citigroup	Neutral → Sell
2022-06-01	업그레이드	Jefferies	Hold → Buy
2022-03-01	개시	Citigroup	Neutral
2022-02-17	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2022-01-25	업그레이드	Stifel	Hold → Buy
2021-11-19	재개	Morgan Stanley	Equal-Weight
2021-09-30	재개	Stifel	Hold
2021-06-04	재개	Robert W. Baird	Outperform
2021-03-31	개시	Credit Suisse	Neutral
2020-12-03	개시	Stifel	Hold
2020-11-02	재확인	H.C. Wainwright	Buy
2020-11-02	다운그레이드	Jefferies	Buy → Hold
2020-10-30	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2020-07-15	재확인	H.C. Wainwright	Buy
2020-05-05	개시	Barclays	Equal Weight
2020-03-17	업그레이드	BMO Capital Markets	Market Perform → Outperform
2020-01-28	개시	BMO Capital Markets	Market Perform
2020-01-27	개시	BMO Capital Markets	Market Perform
2019-11-06	업그레이드	Raymond James	Outperform → Strong Buy
2019-10-22	개시	JMP Securities	Mkt Outperform
2019-10-03	개시	H.C. Wainwright	Buy
2019-09-12	업그레이드	Raymond James	Mkt Perform → Outperform
2019-08-29	개시	Piper Jaffray	Neutral
2019-08-15	재개	Raymond James	Mkt Perform
2019-07-18	개시	Deutsche Bank	Buy
2019-05-23	재개	Goldman	Buy
2019-04-03	개시	Morgan Stanley	Overweight
2018-09-25	개시	Leerink Partners	Outperform
2017-12-11	재확인	Goldman	Buy

모두보기

Blueprint Medicines Corp 주식(BPMC)의 최신 뉴스

03:26 AM

Blueprint Medicines (NASDAQ:BPMC) Upgraded at StockNews.com - Defense World

03:26 AM

02:35 AM

Blueprint Medicines’ (BPMC) Buy Rating Reiterated at HC Wainwright - Defense World

02:35 AM

May 03, 2025

Blueprint Medicines First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

May 03, 2025

Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025

May 02, 2025